Dr. reddy's laboratories announces the launch of icosapent ethyl capsules, 1 gram in the u.s. market

Hyderabad, india and princeton, n.j.--(business wire)--dr. reddy's laboratories ltd. (bse: 500124, nse: drreddy, nyse: rdy, nseifsc: drreddy, along with its subsidiaries together referred to as “dr. reddy's”) today announced the launch of icosapent ethyl capsules, 1 gram approved by the u.s. food and drug administration (usfda). dr. reddy's icosapent ethyl capsules, 1 gram is approved for the following indication: as an adjunct to diet to reduce triglyceride (tg) levels in adult patients with s
RDY Ratings Summary
RDY Quant Ranking